Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticoagulants | 18 | 2021 | 392 | 6.730 |
Why?
|
| Atrial Fibrillation | 14 | 2021 | 531 | 5.400 |
Why?
|
| Venous Thromboembolism | 7 | 2020 | 146 | 3.250 |
Why?
|
| Stroke | 9 | 2021 | 858 | 2.790 |
Why?
|
| Long-Term Care | 5 | 2021 | 164 | 2.170 |
Why?
|
| Postoperative Complications | 6 | 2017 | 882 | 2.100 |
Why?
|
| Arthroplasty, Replacement, Hip | 5 | 2020 | 58 | 2.030 |
Why?
|
| Arthroplasty, Replacement, Knee | 5 | 2020 | 85 | 1.970 |
Why?
|
| Hospitalization | 8 | 2021 | 1062 | 1.540 |
Why?
|
| Cardiologists | 2 | 2019 | 17 | 1.510 |
Why?
|
| Homes for the Aged | 2 | 2021 | 147 | 1.500 |
Why?
|
| Nursing Homes | 4 | 2021 | 531 | 1.450 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 127 | 1.300 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2020 | 680 | 1.300 |
Why?
|
| Activities of Daily Living | 4 | 2021 | 278 | 1.280 |
Why?
|
| Health Personnel | 2 | 2020 | 288 | 1.220 |
Why?
|
| Decision Support Techniques | 3 | 2020 | 154 | 1.210 |
Why?
|
| Pharmacists | 3 | 2021 | 86 | 1.190 |
Why?
|
| Medically Uninsured | 3 | 2016 | 47 | 1.170 |
Why?
|
| Electronic Health Records | 4 | 2021 | 273 | 1.150 |
Why?
|
| Frailty | 3 | 2021 | 86 | 1.140 |
Why?
|
| Aged | 23 | 2021 | 10783 | 1.110 |
Why?
|
| Health Care Reform | 5 | 2016 | 76 | 1.010 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 483 | 0.990 |
Why?
|
| Drug Utilization | 4 | 2020 | 221 | 0.980 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 153 | 0.930 |
Why?
|
| Risk Factors | 12 | 2021 | 4182 | 0.930 |
Why?
|
| Disability Evaluation | 3 | 2017 | 183 | 0.870 |
Why?
|
| Healthcare Disparities | 3 | 2021 | 244 | 0.860 |
Why?
|
| House Calls | 1 | 2020 | 12 | 0.850 |
Why?
|
| Humans | 41 | 2021 | 48426 | 0.840 |
Why?
|
| Patient Transfer | 1 | 2020 | 73 | 0.800 |
Why?
|
| Preoperative Care | 2 | 2020 | 141 | 0.790 |
Why?
|
| Medical Order Entry Systems | 1 | 2020 | 45 | 0.780 |
Why?
|
| Electronic Mail | 1 | 2020 | 47 | 0.780 |
Why?
|
| Clinical Protocols | 1 | 2020 | 123 | 0.770 |
Why?
|
| Warfarin | 2 | 2019 | 101 | 0.760 |
Why?
|
| Insurance Coverage | 3 | 2015 | 94 | 0.760 |
Why?
|
| Reminder Systems | 1 | 2020 | 72 | 0.760 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 4204 | 0.750 |
Why?
|
| Documentation | 1 | 2020 | 102 | 0.740 |
Why?
|
| Male | 23 | 2021 | 23088 | 0.730 |
Why?
|
| Veterans | 2 | 2016 | 509 | 0.720 |
Why?
|
| Self Report | 2 | 2017 | 300 | 0.720 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 1157 | 0.710 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 164 | 0.700 |
Why?
|
| Frail Elderly | 2 | 2021 | 79 | 0.700 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 72 | 0.680 |
Why?
|
| Referral and Consultation | 1 | 2020 | 331 | 0.680 |
Why?
|
| Risk Assessment | 6 | 2021 | 1573 | 0.660 |
Why?
|
| Female | 23 | 2021 | 26167 | 0.660 |
Why?
|
| Quality of Health Care | 1 | 2020 | 469 | 0.620 |
Why?
|
| Guideline Adherence | 1 | 2018 | 269 | 0.620 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 443 | 0.610 |
Why?
|
| Disabled Persons | 1 | 2017 | 178 | 0.560 |
Why?
|
| Quality Improvement | 1 | 2018 | 320 | 0.550 |
Why?
|
| Middle Aged | 14 | 2021 | 13427 | 0.530 |
Why?
|
| Hemorrhage | 3 | 2021 | 218 | 0.530 |
Why?
|
| Massachusetts | 8 | 2021 | 2010 | 0.530 |
Why?
|
| Administration, Oral | 5 | 2021 | 299 | 0.510 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 734 | 0.480 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 156 | 0.470 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 102 | 0.460 |
Why?
|
| Treatment Outcome | 6 | 2021 | 3804 | 0.440 |
Why?
|
| Health Services Accessibility | 3 | 2015 | 429 | 0.430 |
Why?
|
| Age Factors | 5 | 2021 | 1422 | 0.420 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 96 | 0.400 |
Why?
|
| Factor Xa Inhibitors | 2 | 2019 | 31 | 0.380 |
Why?
|
| Transferrin | 1 | 2009 | 69 | 0.370 |
Why?
|
| Pressure Ulcer | 1 | 2008 | 27 | 0.360 |
Why?
|
| United States | 8 | 2021 | 6082 | 0.350 |
Why?
|
| Comorbidity | 3 | 2021 | 1000 | 0.350 |
Why?
|
| Patient Participation | 2 | 2020 | 178 | 0.350 |
Why?
|
| Patient Selection | 2 | 2020 | 341 | 0.350 |
Why?
|
| Wound Healing | 1 | 2008 | 150 | 0.330 |
Why?
|
| Osteomyelitis | 1 | 2007 | 15 | 0.330 |
Why?
|
| Foot Diseases | 1 | 2007 | 15 | 0.330 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 229 | 0.320 |
Why?
|
| Computer Simulation | 1 | 2009 | 411 | 0.320 |
Why?
|
| Time Factors | 4 | 2021 | 3189 | 0.310 |
Why?
|
| Alcoholism | 1 | 2009 | 258 | 0.310 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 984 | 0.300 |
Why?
|
| Retrospective Studies | 4 | 2021 | 4384 | 0.290 |
Why?
|
| Quality Indicators, Health Care | 1 | 2008 | 312 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 596 | 0.290 |
Why?
|
| Mass Screening | 1 | 2009 | 508 | 0.270 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2016 | 30 | 0.250 |
Why?
|
| Prospective Studies | 3 | 2021 | 2473 | 0.220 |
Why?
|
| Medication Systems | 1 | 2021 | 18 | 0.220 |
Why?
|
| Medicare | 2 | 2021 | 434 | 0.210 |
Why?
|
| Advance Care Planning | 1 | 2021 | 39 | 0.210 |
Why?
|
| Preoperative Period | 1 | 2020 | 58 | 0.210 |
Why?
|
| Cardiology | 1 | 2021 | 78 | 0.210 |
Why?
|
| Polypharmacy | 1 | 2020 | 53 | 0.210 |
Why?
|
| Medication Errors | 1 | 2021 | 106 | 0.210 |
Why?
|
| Validation Studies as Topic | 1 | 2020 | 25 | 0.200 |
Why?
|
| Blood Coagulation | 1 | 2020 | 46 | 0.200 |
Why?
|
| Primary Health Care | 2 | 2019 | 547 | 0.200 |
Why?
|
| Knowledge | 1 | 2019 | 26 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2020 | 721 | 0.200 |
Why?
|
| Mobility Limitation | 1 | 2020 | 51 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 1368 | 0.190 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 127 | 0.190 |
Why?
|
| Machine Learning | 1 | 2020 | 84 | 0.190 |
Why?
|
| Safety-net Providers | 2 | 2016 | 25 | 0.190 |
Why?
|
| Self Concept | 1 | 2019 | 106 | 0.190 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 147 | 0.190 |
Why?
|
| Home Care Services | 1 | 2020 | 92 | 0.190 |
Why?
|
| Walking | 1 | 2020 | 164 | 0.190 |
Why?
|
| Accidental Falls | 1 | 2020 | 127 | 0.180 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 63 | 0.180 |
Why?
|
| Case-Control Studies | 1 | 2020 | 882 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 2236 | 0.170 |
Why?
|
| Ambulatory Care | 1 | 2020 | 270 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 178 | 0.170 |
Why?
|
| Adult | 5 | 2020 | 13163 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2018 | 400 | 0.160 |
Why?
|
| Models, Econometric | 1 | 2016 | 12 | 0.160 |
Why?
|
| Markov Chains | 1 | 2016 | 28 | 0.160 |
Why?
|
| Patient Discharge | 1 | 2020 | 405 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2018 | 717 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 490 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2013 | 2043 | 0.150 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 36 | 0.150 |
Why?
|
| Reoperation | 1 | 2016 | 179 | 0.150 |
Why?
|
| Gait | 1 | 2016 | 90 | 0.150 |
Why?
|
| Analgesics, Opioid | 2 | 2010 | 322 | 0.140 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 13 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 696 | 0.140 |
Why?
|
| Young Adult | 3 | 2015 | 3600 | 0.140 |
Why?
|
| Length of Stay | 1 | 2017 | 620 | 0.130 |
Why?
|
| Thrombosis | 1 | 2015 | 187 | 0.130 |
Why?
|
| Adolescent | 3 | 2015 | 5292 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 174 | 0.120 |
Why?
|
| Urinalysis | 1 | 2010 | 30 | 0.100 |
Why?
|
| Health Status | 1 | 2013 | 402 | 0.100 |
Why?
|
| Poverty | 1 | 2012 | 282 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2010 | 97 | 0.100 |
Why?
|
| Logistic Models | 1 | 2013 | 1168 | 0.100 |
Why?
|
| Decision Trees | 1 | 2009 | 46 | 0.100 |
Why?
|
| Review Literature as Topic | 1 | 2009 | 34 | 0.090 |
Why?
|
| Dihydroergotamine | 1 | 2008 | 2 | 0.090 |
Why?
|
| Meperidine | 1 | 2008 | 3 | 0.090 |
Why?
|
| Ketorolac | 1 | 2008 | 14 | 0.090 |
Why?
|
| Paralysis | 1 | 2008 | 14 | 0.090 |
Why?
|
| Terminally Ill | 1 | 2008 | 17 | 0.090 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2008 | 31 | 0.090 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 177 | 0.090 |
Why?
|
| Migraine Disorders | 1 | 2008 | 39 | 0.090 |
Why?
|
| Pain | 1 | 2010 | 297 | 0.080 |
Why?
|
| Technetium | 1 | 2007 | 45 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2007 | 92 | 0.080 |
Why?
|
| Radionuclide Imaging | 1 | 2007 | 97 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 176 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2007 | 103 | 0.080 |
Why?
|
| Radiography | 1 | 2007 | 338 | 0.080 |
Why?
|
| Sex Factors | 1 | 2008 | 846 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2010 | 271 | 0.070 |
Why?
|
| Biomarkers | 1 | 2009 | 953 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2007 | 759 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 943 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 754 | 0.050 |
Why?
|
| Natural Language Processing | 1 | 2021 | 47 | 0.050 |
Why?
|
| Eligibility Determination | 1 | 2020 | 29 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 93 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 180 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2021 | 235 | 0.050 |
Why?
|
| Language | 1 | 2021 | 115 | 0.050 |
Why?
|
| Focus Groups | 1 | 2020 | 251 | 0.050 |
Why?
|
| Sepsis | 1 | 2021 | 208 | 0.050 |
Why?
|
| Prevalence | 1 | 2021 | 1107 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 379 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 1244 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 69 | 0.040 |
Why?
|
| Global Health | 1 | 2015 | 137 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 467 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 1110 | 0.030 |
Why?
|
| Health Services | 1 | 2012 | 84 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2010 | 680 | 0.020 |
Why?
|